PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,217,773 | fabric high effici wood base solar interfaci evapor self desalt steril perform solar interfaci evapor base wood deriv materi consid promis strategi desalin wastewat purif herein adopt delignifi wood dw water transport substrat lignosulfon ls modifi narrow band gap semiconductor nickel disulfid nis light absorb agent ls nis fabric high effici evapor ls nis dw one hand high absorb within broad wavelength rang excel phototherm convers effici ls nis endow effici solar energi util hand hydrophil dw facilit water activ result lower evapor enthalpi ls nis dw kj kg pure water combin ls nis dw ls nis dw achiev evapor rate high kg h one sun irradi kw evapor effici reach notabl ls nis dw exhibit high evapor rate kg h simul seawat h salt crystal form surfac moreov ls nis dw show high antibacteri activ reduct bacteri surviv rate work could provid new perspect design high effici wood base phototherm evapor | D014934;D009532 | T167;T123;T196 |
36,217,771 | acoust tether microorgan show construct appli setup acoust tether enabl behavior observ individu microorgan use simpl laboratori equip standard light microscop explor capabl setup freeli swim dinoflagel alexandrium minutum studi organ setup allow us tether cell focus mid plane sampl chamber make observ individu organ high magnif without affect flagellar beat frequenc discuss prospect method explor appendag motion swim kinemat flagel ciliat argu method applic broad rang cell size shape | D004141 | T204 |
36,217,766 | dynam fluoresc probe glycolysi suppress process hela cell treat trichostatin acetyl regul histon deacetylas hdac histon acetyltransferas hat imbal hdac hat lead cancer trichostatin tsa one typic hdac inhibitor hdaci may regul acetyl level thus prevent prolifer cancer cell metabol chang glycolysi involv howev dynam process glycolysi yet explor mechan still elus work construct gfp actin hela cell observ dynam chang glycolysi situ found gfp fluoresc enhanc signific tsa treatment consist chang ph cell ph depend chang lactat origin glycolysi furthermor confirm glycolysi inhibit tsa treatment process associ hif c myc regul work demonstr use gfp fluoresc probe monitor metabol process glycolysi situ also shed new light mechan glycolysi suppress cancer cell treat hdaci | D006655;D006019 | T026;T044;T126;T116 |
36,217,765 | polyethyleneimin base immunoadjuv design cancer vaccin despit extens effort improv effect cancer vaccin lack immunogen remain issu adjuv requir enhanc immunogen antigen activ immun respons howev adjuv accept toxic suffici potenc use cancer vaccin necessit discoveri potent adjuv well known cation polym polyethyleneimin pei act carrier deliv antigen immunoadjuv enhanc innat adapt immun review summar pei base adjuv discuss improv boost immun respons vaccin focus pei base adjuv cancer vaccin final propos potenti challeng futur issu pei base adjuv elicit effect cancer vaccin | D019496;D009369 | T121;T191;T116;T129 |
36,217,764 | develop iranian sub nation primari health care measur framework studi protocol develop effect system measur improv primari health care phc base condit characterist countri health system one world health organ recommend | D003695;D011320 | T093;T058 |
36,217,743 | multifunct nanoreactor nutrient consumpt ros generat capabl antibacteri skin repair bacteri wound infect brought serious threat human health caus huge econom loss attempt develop biomateri excel antibacteri effect meaning promot wound heal herein report multifunct nanoreactor nutrient consumpt reactiv oxygen speci ros generat capabl antibacteri skin wound repair nanoreactor construct encapsul glucos oxidas gox cu dope zeolit base imidazol framework zif one pot synthesi method nanoreactor consum nutrient bacteria gox driven oxid reaction also generat high toxic hydroxyl radic oh kill bacteria via cu mediat fenton like reaction moreov zn releas nanoreactor also capabl exhibit synergist antibacteri activ addit mediat fenton like reaction cu promot angiogenesi acceler wound heal thus multifunct nanoreactor abil cut nutrient suppli starv bacteria produc ros kill bacteria promot angiogenesi acceler wound heal enabl promis treatment wound infect | D000900;D014946 | T121;T046;T195 |
36,217,718 | accur detect perchlor epoxi resin via chlorin quantit quadrupolar nmr qqnmr qqnmr methodolog use chlorin employ quadrupolar nucleus introduc first time robust valid method determin quantifi perchlor epoxi resin quantif carri use calibr curv lithium perchlor method valid seven concentr level rang mg ml mm perchlor afford intra inter day accuraci lower express cv robust toward ph temperatur resin concentr recycl delay limit detect lod mg ml mm perchlor limit quantif loq mg ml mm perchlor probabl import applic matrix effect method appli epoxi resin contain three differ type perchlor precursor lithium potassium tetramethylammonium afford excel quantif relat error compar spike concentr | D010472;D002713 | T131;T196;T197 |
36,217,690 | heterojunct mno nanosheet decor ag nanowir enhanc oxidas like activ sensit dual mode detect glutathion biocatalyt design nanomateri enzym like activ consid reliabl promis toolkit generat diagnost agent complex biolog microenviron howev prepar nanomateri maintain high catalyt activ tumor cell ph pose promin challeng herein construct biomimet enzym trig dual mode system colorimetri nm phototherm biosensor detect glutathion base hollow mno nanosheet decor ag nanowir ag mno oxidas like nanozym expect ag mno catalyz oxid tetramethylbenzidin tmb absenc h lead blue color oxid tmb oxtmb display oxidas like activ ph interest portabl dual mode colorimetri phototherm method gsh develop base redox reaction gsh oxtmb detect method exhibit wide linear rang gsh low detect limit work highlight new insight nanotechnolog take advantag biomimet design biolog analysi | D017895;D053770 | T073;T197 |
36,217,676 | bioethic forum cardiolog young quo vadi editori board cardiolog young recent discuss need bioethic forum given authoris proceed creation herein provid organis structur launch process introduc proper interest time endeavour communic establish bioethic forum cardiolog young hope attract manuscript concern time bioethic subject offer readership opportun respond topic support oppos view appropri new articl regard time topic written readership well invit author articl publish hope stimul interact discuss concern publish manuscript manuscript associ discuss open interest parti | D001675;D002309 | T091 |
36,217,671 | nanoenzym chitosan hydrogel complex cascad catalyt self reinforc antibacteri perform acceler heal diabet wound signific disabl fatal rate diabet chronic wound necessit develop effici diabet wound heal techniqu present oxygen treatment wound heal restrict issu poor penetr inadequ suppli absorpt difficulti well tanglesom diabet wound microenviron issu hyperglycemia excess reactiv oxygen speci ros hypoxia herein design multifunct glucos oxidas gox catalas cat nanoenzym chitosan gcnc hydrogel complex improv microenviron diabet wound provid continu oxygen deliveri effici wound heal simultan form gox cat nanoenzym gcne composit gcnc hydrogel complex could effect reduc glucos ros h concentr diabet wound cascad catalyt reaction achiev continu oxygen suppli promot cell prolifer migrat angiogenesi therebi acceler diabet wound heal addit byproduct glucon acid produc cascad reaction activ amino group chitosan reinforc antibacteri perform prevent microbi infect multifunct gcnc hydrogel complex continu oxygen suppli self reinforc antibacteri properti byproduct free featur provid general strategi repair extens tissu damag diabet | D048271;D003920 | T121;T047;T109 |
36,217,667 | covid pandem influenc suicid rate differenti accord socioeconom indic ethnic evid need global covid pandem harm mani peopl mental health global whilst evid generat thus far high incom countri regard pandem impact suicid rate general reassur know littl influenc outcom lower middl incom countri among marginalis disadvantag peopl signal concern regard pandem potenti unequ impact suicid rate affect demograph subgroup region elev risk pandem began howev evid base topic current spars studi conduct date general taken account pre pandem tempor trend collect accur complet compar data suicid rate trend ethnic minor low incom group prioritis vulner low incom group like exacerb current energi suppli cost live crise mani countri therefor crucial reassur messag highlight stabil suicid rate pandem lead complac among policymak | D000086382;D013405 | T047;T067;T033 |
36,217,664 | strategi prevent postop recurr adenoid hypertrophi adenoid hypertrophi common diseas pediatr otorhinolaryngolog surgic resect main treatment present mani children still face risk postop recurr even secondari surgeri order reduc postop recurr rate provid refer inform clinic medic staff parent children review carri analyz domest foreign pertin literatur recent year put forward overal prevent strategi base relat factor recurr | D000234 | T023 |
36,217,663 | new progress diagnosi treatment hpv posit oropharyng carcinoma recent year incid oropharyng carcinoma opc increas better prognosi patient human papillomavirus hpv posit oropharyng carcinoma confirm number studi varieti detect method hpv associ oropharyng carcinoma includ p immunohistochemistri polymeras chain reaction pcr situ hybrid ish detect hpv dna hpv rna rever transcriptas polymeras chain reaction rt pcr use detect hpv rna better prognosi patient hpv posit oropharyng carcinoma led emerg larg number degrad treatment trial tradit p test certain limit diagnosi patient hpv posit oropharyng carcinoma necessari combin detect method accur screen patient hpv posit oropharyng carcinoma better appli degrad therapi articl briefli introduc trend hpv associ oropharyng carcinoma detect method new progress degrad treatment trial | D002294;D009959;D030361 | T191;T047 |
36,217,662 | audiolog phenotyp kbg syndrom case report literatur review kbg syndrom uncommon autosom domin inherit diseas involv multipl system caus mutat ankrd gene patient seri symptom includ hear loss short statur macrodontia upper central incisor mental retard diagnos kbg syndrom pure tone audiometri show bilater conduct hear loss tempor bone ct suggest deform ossicular chain bilater middl ear x ray show bone age five year old import genet test prompt de novo mutat ankrd aim articl briefli analyz audiolog phenotyp characterist kbg syndrom hope improv clinic attent diseas | D000015;D001848;D008607;D014071 | T047;T190;T019;T048 |
36,217,661 | summari experi cochlear implant surgeri tibet analysi postop rehabilit effect cochlear implant surgeri recogn effect intervent patient sever profound sensorineur hear loss due various factor high altitud low oxygen content ethnic differ tibet earli hear screen found incid neonat hear loss signific higher mainland great assist china disabl person feder first cochlear implant surgeri carri tibet total case complet articl aim summar clinic experi cochlear implant surgeri tibet ten year retrospect analyz postop rehabilit effect improv understand cochlear implant surgeri plateau area | D019929;D003054;D006319;D013067 | T061;T047;T074;T041 |
36,217,660 | surgic method cerebrospin fluid otorhinorrhea due inner ear malform children object discuss applic two surgic method tran mastoid approach tran canal endoscop approach treatment cerebrospin fluidcsf otorhinorrhea due inner ear malformationiem children method children csf otorhinorrhea due iem juli jan ent depart beij children hospit retrospect analyz clinic data surgic method complic recurr follow record result children csf otorhinorrhea due iem includ half histori otorhinorrhea diagnos cerebrospin fluidcsf otorrhea first onset unilater bilater iem case case respect unilater iem children secondari infect mening orand pneumonia cochlear implantationci due deaf mening bilater iem children ci due profoundsever hear loss csf otorhinorrhea unilater relationship csf otorhinorrhea malform side time ci surgeri tran mastoid approach use case usual involv ci oper endoscop approach case age tran mastoid group younger endoscop group recurr complic occur tran mastoid group endoscop group case recur case complic temporari facial paralysi labyrinth intracrani pneumatosi except one case lost other follow year recurr pneumonia mening csf otorhinorrhea happen conclus unilater iem usual lead mening orand pneumonia bilater iem requir ci tran mastoid tran canal endoscop approach effect csf otorrhea repair tran mastoid approach suitabl need mastoid explor ci combin oper tran canal endoscop approach choos fistula confin tympanum ear canal diamet wide enough | D007758;D008581 | T023;T047 |
36,217,659 | applic computer cognit behavior therapi patient persist postur perceptu dizzi object computer cognit behavior therapi intervent program construct patient persist postur percept dizzinesspppd effect dizzi symptom negat emot balanc function investig method random control trial design use select patient pppd seen depart otorhinolaryngolog head neck surgeri first hospit shanxi medic univers juli juli random assign control group patient experiment group patient control group routin treat medic vestibular rehabilit experiment group underw computer cognit behavior therapi total session week dizzi symptomsdhi negat affectgad phq balanc functionbb compar baselin week later result week intervent improv dizzi symptom negat mood group group effect time effect interact effect p improv balanc function time effect interact effect p conclus computer cognit behavior therapi use adjunct treatment allevi patient dizzi negat affect balanc function addit benefit seen term balanc function improv | D015928;D015837 | T061;T047 |
36,217,658 | predict valu strobovideolaryngoscopi acoust aerodynam measur prognosi tempor unilater vocal fold paralysi thyroidectomi object investig strobovideolaryngoscopi acoust aerodynam characterist transient unilater vocal ford paralysisuvfp thyroidectomi method retrospect analysi made patient temporari uvfp thyroidectomi treat depart otolaryngolog head neck surgeri sun yat sen memori hospit sun yat sen univers januari march patient perman uvfp thyroidectomi period includ control group differ baselin strobovideolaryngoscopi acoust aerodynam measur compar two group result tone patient temporari uvfp thyroidectomi normal proport abnorm vocal fordsvoc ford bow atrophi shorten ventricular adduct glottic insuffici signific lower perman uvfp patient arytenoid cartilag stabil height mismatch vocal ford tend better perman uvfp maxim phonat timempt patient temporari uvfp signific longer patient perman uvfp fundament frequenc mean airflowmeaf mean subglott pressuresgp better temporari uvfp patient perman uvfp differ reach statist signific conclus none mild glottic insuffici normal tone ventricular adduct vocal ford appear without vocal fold bow atrophi shorten serv predictor earli recoveri vocal ford movement temporari uvfp thyroidectomi mpt less meaf sgp remark increas predictor poor prognosi vocal ford recoveri | D013965;D014826 | T061;T047;T033 |
36,217,657 | clinic observ high select vidian neurectomi guid palatovagin canal object summar safeti feasibl high select vidian neurectomi guid palatovagin canal method hypotherm plasma surgeri perform patient perenni allerg rhiniti par remov soft tissu cover anterior wall sphenoid process palatin bone use coblat system find palatovagin canal cut neurovascular bundl palatovagin canal expos anterior orific vidian canal cut vidian nerv result par patient conduct novel vidian neurectomi without sphenopalatin arteri trunk damag secondari hemorrhag hard palat numb happen symptom nasal obstruct sneez nasal discharg rhinocnesmus reliev signific conclus simpl safe approach high select vidian neurectomi guid palatovagin canal provid altern surgic option clinician | D012221;D013101 | T047;T030 |
36,217,656 | analysi risk factor oper due postop haemorrhag follow coblat assist tonsillectomi object investig risk factor oper due postop haemorrhag follow coblat assist tonsillectomi method clinic data patient haemorrhag coblat assist tonsillectomi hospit januari may collect accord patient receiv reoper tonsillectomi patient divid reoper group n non reoper group n clinic data compar two group result univari analysi show signific differ gender age postop intraven glucocorticoid use diabet hypertens two group p univari multivari factor analys show earli haemorrhag obvious hemorrhag point independ risk factor oper due postop haemorrhag p conclus earli haemorrhag obvious hemorrhag point independ risk factor oper due postop haemorrhag follow coblat assist tonsillectomi | D014068 | T061 |
36,217,655 | cross cultur adapt clinic applic menier diseas outcom questionnair object cross cultur adapt menier diseas outcom questionnairemdoq chines languag evalu reliabl valid appli clinic method mdoq translat accord brislin model cross cultur adapt done expert discuss pilot studi mdoq appli patient test reliabl valid qualiti lifeqol patient measur mdoq c analyz influenc factor qol patient menier diseas result cr valu item mdoq c exceed cronbach coeffici spearman brown coeffici pearson correl coeffici mdoq c dhi p three factor extract factor analysi could explain total varianc dimens composit differ origin scale averag qol score menier diseas patient main influenc factor age marit status work status tinnitus number vertigo attack conclus mdoq c reliabl valid dimens reconstruct mdoq c use evalu qol patient menier diseas preliminari clinic applic influenc factor qualiti life patient menier diseas identifi thus provid refer optim clinic manag strategi | D008575 | T047 |
36,217,654 | preliminari studi efficaci safeti submucos plasma ablat inferior turbin children allerg rhiniti complic obstruct sleep apnea syndrom object studi aim investig long term clinic efficaci safeti inferior turbin submucos plasma ablat combin without tonsillar adenoid surgeri children allerg rhinitisar combin obstruct sleep apnea syndromeosa ineffect conserv system treatment method total children ar complic osa met inclus criteria among children hospit januari februari retrospect analyz data collect includ clinic characterist surgic method periop manag prevent treatment complic moreov one year follow perform compar vas score children surgeri evalu mid term long term outcom result averag oper time minut meanwhil intraop blood limit symptom nasal congest runni nose sleep snore mouth breath signific improv oper result satisfactori one year follow without complic bleed hematoma intraop adhes nasal dryness conclus submucos plasma ablat inferior turbin without tonsillectomi adenoidectomi children ar effect improv clinic symptom ar combin osa children ineffect conserv treatment improv symptom sleep disord breath sleep snore mouth breath good mid long term curat effect fewer complic effect safe treatment children ar combin osa | D065631;D020181;D014068 | T061;T047 |
36,217,653 | one stage technolog epiglotti function voic reconstruct total laryngectomi sternohyoid myocutan flap object investig clinic effect one stage sternohyoid musculocutan flap total laryngectomi reconstruct epiglotti function vocal method retrospect analysi patient underw total laryngectomi novemb septemb sternohyoid myocutan flap design total laryngectomi lower edg flap sew posterior upper edg tracheostomi open later medial edg flap anastomos creat vocal tube later edg upper end tube sutur anterolater wall hypopharynx made full use residu epiglotti tongu root tissu reconstruct epiglotti function result none patient serious complic total laryngectomi fifteen month oper vocal tube flap surviv intact structur fiberopt laryngoscop patient could speak clear forc swallow function intact conclus use adjac myocutan flap construct vocal canal reconstruct epiglotti function simpl effect techniqu complet one stage improv voic patient undergo total laryngectomi | D007822;D064827;D019651 | T191;T061;T024 |
36,217,652 | applic print nasal vestibular support treatment anterior nostril stenosi object evalu efficaci print nasal vestibular support recoveri nasal ventil function nostril shape nostril stenosi treatment method thirti eight patient unilater traumat nasal vestibular stenosi select treat print nasal vestibular support oper subject evalu indic object nostril local morpholog structur paramet nasal airflow dynam paramet numer simul use evalu nostril morpholog nasal function recoveri treatment result subject nasal congest nostril symmetri satisfact vas score patient nasal vestibular support treatment improv vari degre compar surgeri nostril morpholog paramet show long axi ratio short axi ratio signific decreas nasal vestibular support therapi compar surgeri respect p cross section area nasal valv stenot side nasal caviti increas cm oper cm treatment p nasal resist stenosi side nasal caviti also decreas pasml oper pa sml treatment p total nasal resist decreas pasml oper pa sml treatment p also show nwenas warm effici nhenas humidif effici stenot side nasal caviti signific decreas nasal vestibular support therapi compar surgeri respect p conclus print nasal vestibular support postop support treatment patient anterior nostril stenosi reflect advantag person treatment allow patient obtain satisfactori result use individu design print nasal vestibular support make shape anterior nostril nasal caviti normal ventil function recov well clinic applic prospect worth look forward | D009668;D012225 | T061;T047 |
36,217,651 | characterist vestibular evok myogen potenti unilater menier diseas patient differ clinic stage object studi retrospect analyz result vestibular evok myogen potentialsvemp unilater menier diseasemd patient method clinic assess result md patient visit depart januari februari review unilater md patient met inclus exclus criteria divid three group accord clinic stage name group stage stage group stage group stage normal valu data use investig incid abnorm p n latenc abnorm p n interwav latenc abnorm interaur amplitud asymmetri ratioiar afterward consid mention paramet vemp result patient grade four levelsgrad mean vemp result normal grade mean vemp result abnorm differ degre correl vemp result level pure tone averagepta md patient differ clinic stage examin result preval cvemp three group respect p preval ovemp three group respect p cvemp ovemp result level signific correl pta r p r p respect conclus progress md function saccul vestibular inferior nerv pathway utricl vestibular superior nerv pathway would deterior way hear | D008575;D058585;D014722 | T047;T023;T034 |
36,217,650 | correl tempor bone hrct slca gene hear loss enlarg vestibular aqueduct object explor correl high resolut comput tomographyhrct tempor bone slca gene mutat hear loss patient enlarg vestibular aqueducteva method medic record subject hospit moder sever sensorineur hear loss depart otolaryngolog head neck surgeri hainan general hospit may retrospect review includ case receiv audiolog examin hrct scan tempor bone slca gene sequenc accord valvassori standard case diamet common peduncl semicircular canal midpoint outer orific vestibular aqueductmp mm diamet outer orific vestibular aqueductop mm diagnos eva case ear eva studi age month year old base hear chang birth growth ear classifi stabl hear group ear unstabl group moreov involv case group mp mm mm op signific correl sever hear loss p eva patient diagnos hrct posit slca gene mutat posit rate eva slca gene sequenc high consist hrctkappa conclus size mp op eva patient relat degre hear loss stabl natur hear loss tempor bone hrct scan slca gene sequenc high consist diagnosi eva latter radiat combin hear screen earli diagnosi eva | D003638;D034381;D006319;D000076988;D014723 | T047;T023;T116;T123;T184;T033 |
36,217,649 | differ treatment method efficaci analysi otiti media effus children differ hear loss object explor analyz treatment method effect otiti media effus children differ hear loss method clinic data children ear otiti media effusionomeadmit depart otorhinolaryngolog head neck surgeri children hospit affili zhejiang univers medicin januari decemb collect differ treatment method select accord degre hear loss combin cours diseas characterist effus tympan caviti divid drug treatment group critic hear loss mild hear loss cours diseas less month myringotomi group mild hear loss cours diseas month moder sever hear loss cours diseas month tympan effus rarefi liquid tympanostomi tube insert group mild hear loss cours diseas month moder sever hear loss group cours diseas month tympan effus sticki jelli liquid moder sever hear loss group cours diseas month children adenoid hypertrophi tonsillar hypertrophi adenoid hypertrophi diagnos obstruct sleep apnea hypopnea syndromeosa underw endoscop adenoidectomi tonsillectomi adenoidectomi curat effect recurr differ treatment group compar result drug treatment group myringotomi group follow month oper tympanostomi tube insert follow everi three month oper averag one year patient follow month take tube effect rate drug treatment group myringotomi group tympanostomi tube insert group respect three group recur ear respect differ statist signific tympan membran perfor left ear ear tympan tube group ear myringotomi group multivari logist regress analysi show allerg rhiniti ci p factor influenc therapeut effect ome conclus treatment ome children combin cours diseas also combin differ hear loss characterist effus tympan caviti differ treatment method get effect low recurr rate small damag satisfactori safeti allerg rhiniti affect therapeut effect ome | D003638;D034381;D010033;D010034;D065631 | T047;T184;T033 |
36,217,645 | effect singl dose premed piroxicam prednisolon post endodont pain one visit root canal treatment random clinic trial object studi compar effect premed drug includ singl dose piroxicam prednisolon regard post endodont pain differ time interv hour singl visit root canal treatment | D010894;D011671 | T121;T047;T109 |
36,217,644 | develop revers discolour root fill ledermix doxymix past store dark three month daylight twenti four month explor long term effect discolour demeclocyclin hcl ledermix led doxycyclin hyclat doxymix dox past place extract human teeth month period differ storag condit | D003707;D004318 | T121;T109;T195 |
36,217,643 | evalu bacteri reduct various stage endodont retreat use differ disinfect regimen vivo studi present studi conduct evalu presenc aerob bacteria anaerob bacteria e faecali f nucleatum propionibacteria sp actinomyc sp reduct various stage endodont retreat use convent protocol sodium hypochlorit naocl irrig along calcium hydroxid ca oh intracan medica advoc protocol smearoff irrig along chlorhexidin chx gel intracan medica | D010485;D012388 | T047;T122 |
36,217,642 | vitro comparison mta bc rrm fast set putti retrograd fill materi compar vitro bioceram materi mta bc rrm fast set putti capac prevent microleakag enterococcus faecali time | D012387 | T122 |
36,217,641 | assess effect supplementari method residu fill materi remov use micro comput tomographi systemat review meta analysi vitro studi systemat review meta analysi conduct evalu effect auxiliari method remov residu fill materi rfm systemat review regist intern prospect regist systemat review registr number crd comprehens literatur search conduct identifi relev articl electron databas pubm embas cochran januari march vitro studi investig compar least one type supplementari method techniqu includ total studi select record obtain screen databas ten includ studi suitabl meta analysi strong evid show ultrason activ irrig uai smd ci p xp endo finish r xpr smd ci p contribut signific increas remov procedur xpr signic superior uai smd ci p strong evid found support increas clean effici supplementari use gentl wave system laser irradi xp endo finish self adjust file contrast conflict evid found support use sonic improv remov rfm limit evid found support effici tornado brush vitro condit uai xpr increas remov rfm root canal system retreat procedur | D012387;D012389 | T061;T122 |
36,217,640 | influenc remnant silicon oil penetr three differ sealer dentin tubul confoc laser scan microscopi studi aim studi assess penetr ah plus mta fillapex guttaflow bioseal sealer dentin tubul placement remov silicon oil use confoc laser scan microscopi | D004853;D012827 | T122 |
36,217,639 | vitro evalu effect intracan medica viabil prolifer differenti stem cell apic papilla systemat review systemat review aim evalu cytotox intracan medica use root canal disinfect assess effect prolifer differenti potenti stem cell apic papilla scap pubmedmedlin cochran scopus embas cinahl web scienc databas search studi evalu effect intracan medica human scap vitro primari cell cultur experi includ systemat review risk bias analysi includ studi carri use toxicolog data reliabl assess tool data analys qualit characterist meta analysi carri consid heterogen select studi term cell cultur experi method analysi interpret result four studi fulfil desir inclus criteria differ antibiot past intracan concentr lead reduct scap surviv compar calcium hydroxid medica find insuffici make clear distinct differ antibiot past regard cytotox within limit present systemat review conclud calcium hydroxid relat better intracan medica antibiot past mixtur term cytotox effect prolifer scap | D000900;D002126 | T121;T197;T195 |
36,217,638 | comparison physicochem properti antimicrobi action cytotox ambroxol hydrochlorid n acetylcystein calcium hydroxid past evalu solubl ph antimicrobi action cytotox ambroxol hydrochlorid amb n acetylcystein nac calcium hydroxid ch past use intracan medic | D000551;D000890 | T121;T109 |
36,217,637 | cyclic fatigu torsion strength new thermal treat reciproc system studi evalu resist cyclic fatigu torsion strength prima one gold waveon gold reciproc system | D003799;D008422;D019415 | T060;T067;T057;T062 |
36,217,636 | effect blue heat treatment vertic forc induc endodont file evalu vertic forc induc reciproc r reciproc blue rb system canal shape | D018915;D012973 | T121;T061;T197 |
36,217,630 | patient advanc lung squamous cell carcinoma fail benefit albumin bound paclitaxel plus pembrolizumab achiev partial respons second line treatment docetaxel plus pembrolizumab case report lung cancer includ squamous cell lung cancer non squamous non small cell lung cancer nsclc lead caus cancer relat death present squamous cell lung cancer patient progress first line chemotherapi plus immunotherapi immunotherapi appli across line still inconclus therefor treatment patient often challeng | D002289;D002294;D008175 | T191 |
36,217,629 | rare complic caus thrombus shed arterioven fistula thrombolysi case report arterioven fistula lifelin mainten patient requir hemodialysi thrombosi common complic procedur tradit thrombi remov via thrombectomi recent year report newli occur thrombi treat urokinas thrombolysi howev thrombus shed process valu may caus distal limb ischemia syndrom complic thrombolysi rare serious patient experi pain numb possibl even extrem necrosi may occur without diagnos treat time report occurr treatment distal limb ischemia syndrom caus thrombus shed thrombolysi | D001164;D013927 | T046;T190 |
36,217,628 | intradur disc herniat l level case report literatur review intradur lumbar disc herniat ildh special type lumbar disc herniat lumbar nucleus pulposus prolaps enter dura mater ildh compris herniat disc case diagnosi could confirm preoper identifi typic featur ildh radiolog evalu current report present case ildh lumbar level discuss clinic present typic imag featur treatment outcom | D007405;D013125 | T191;T047 |
36,217,627 | hypertens rare advers effect caus infliximab treatment crohn diseas case report infliximab effect drug treatment crohn diseas rare uniqu advers effect infliximab hypertens paid enough attent clinic work present relev case report report case year old man crohn diseas histori hypertens develop hypertens symptom infliximab treatment | D003424;D064420 | T047;T046;T037 |
36,217,626 | effect combin acupunctur exercis train reliev dyspnea improv exercis toler chronic obstruct pulmonari diseas patient protocol singl blind random sham control trial exercis train benefici patient chronic obstruct pulmonari diseas copd howev effect exercis train limit patient impair exercis capac exert dyspnea respiratori problem acupunctur reliabl safe therapi effect reduc dyspnea reliev respiratori muscl fatigu improv exercis capac copd patient howev known whether combin exercis train acupunctur reduc dyspnea improv qualiti life copd patient induc pronounc effect dyspnea exercis toler trial aim determin whether acupunctur enhanc effect exercis train copd patient compar sham acupunctur | D015670;D029424 | T061;T047 |
36,217,625 | retrospect compar cohort studi effect neural mobil nm alon nm combin transcrani direct current stimul patient cervic radiculopathi transcrani direct current stimul tdcs neural mobil nm wide use clinic practic two effect treatment howev exist studi combin two treatment particular cervic radiculopathi cr explor valu combin tdcs nm manag pain disabl qualiti life qol patient cr author design studi | D011843;D065908 | T061;T047;T037 |
36,217,624 | characterist prognost outcom factor young elder periton dialysi patient prospect cohort studi periton dialysi pd main renal replac therapi elder patient account hemodynam stabil clinic characterist prognosi elder pd patient vari differ dialysi center analyz characterist outcom prognosi factor surviv elder pd patient china better understand status improv qualiti life | D002318;D007676;D010530 | T061;T047 |
36,217,623 | efficaci safeti adjunct nebul colistin sulfat multidrug resist gram negat bacteria pneumonia retrospect compar cohort studi incid multidrug resist gram negat bacteria mdr gnb pneumonia increas last decad antibiot given intraven antibiot concentr lung tissu insuffici recent nebul antibiot shown effect adjunct therapi intraven antibiot resist strain therefor goal studi assess efficaci safeti adjunct nebul colistin sulfat combin intraven antibiot patient mdr gnb pneumonia | D058633;D053717 | T121;T047;T039 |
36,217,622 | prospect analysi prognost valu prenat mri measur cystic volum ratio fetal congenit cystic adenomatoid malform cystic volum ratio cvr use predict prognosi fetal lung diseas report ultrasound purpos studi investig prognost valu prenat magnet reson imag mri measur cvr fetal congenit cystic adenomatoid malform ccam | D015615;D005315 | T047;T019 |
36,217,621 | effect earli vs late ct guid stereotact hematoma aspir neurolog function recoveri patient hypertens cerebr hemorrhag basal ganglia retrospect compar cohort studi surgeri play major role treat hypertens cerebr hemorrhag basal ganglia howev patient suffer neurolog impair surgeri studi confirm stereotact hematoma aspir guid comput tomographi ct signific valu patient hypertens intracerebr hemorrhag basal ganglia littl known optim time oper studi sought explor effect ct guid stereotact hematoma aspir time recoveri neurolog function patient hypertens cerebr hemorrhag basal ganglia | D020299;D020521 | T047;T046 |
36,217,620 | effect electroacupunctur dexmedetomidin myocardi ischemiareperfus injuri rat investig protect effect electroacupunctur combin dexmedetomidin ea dex oxid stress injuri myocardi ischemiareperfus ir rat | D020927;D015671;D009203;D017202;D015428 | T047;T046;T061;T121;T109 |
36,217,619 | correl serum nicotinamid phosphoribosyl transferas hypoxia framingham risk score patient obstruct sleep apnea hypopnea syndrom obstruct sleep apnea hypopnea syndrom osah independ risk factor atherosclerosi mechan differ classic risk factor nicotinamid phosphoribosyltransferas nampt involv pathophysiolog via multipl pathway express close relat hypoxia associ nampt hypoxia risk cardiovascular morbid patient osah remain defin therefor carri studi investig associ nampt hypoxia risk earli cardiovascular diseas base framingham risk score frs patient osah | D002318;D054409;D020181 | T047;T126;T116 |
36,217,618 | develop valid risk predict model post traumat stress disord symptom patient acut myocardi infarct china present mani influenc factor post traumat stress disord ptsd symptom patient acut myocardi infarct ami base studi risk predict model ptsd symptom aim studi investig risk factor ptsd symptom patient ami construct risk predict model | D009203;D013313 | T047;T048 |
36,217,617 | peripher white blood cell subtyp developmentprogress diabet macular edema type diabet patient compar studi inflamm immun dysregul involv pathogenesi diabet macular edema dme progress increas neutrophil peripher blood lead increas number neutrophil retina thus lead sustain damag retin vascular system destruct blood retin barrier brb lymphocyt play protect role vascular diseas caus type diabet mellitus tdm purpos studi studi relationship chang leukocyt classif peripher blood occurr progress dme patient tdm | D003924;D003930;D008269 | T047 |
36,217,616 | applic clearanc rate inflammatori marker evalu therapeut effect adult bacteri bloodstream infect bloodstream infect bsi serious system infecti diseas studi aim investig applic clearanc rate interleukin procalcitonin c reactiv protein evalu antimicrobi efficaci adult bacteri bsi without inflammatori factor | D016470;D003141;D018805 | T047;T046 |
36,217,615 | comparison anxieti depress symptom head neck cancer patient close loop manag system coronavirus pandem compar studi coronavirus diseas covid pose unpreced challeng health financi system especi healthcar patient cancer howev research negat effect pandem anxieti depress symptom cancer patient close loop rare report present view limit previous studi studi compar anxieti depress symptom head neck cancer patient close loop manag system coronavirus pandem | D000086382;D006258 | T191;T047;T067 |
36,217,611 | bodipi base multichromophor tripod system multifunct materi strateg design synthesi thorough character redox activ bodipi base tripod system tri bdp display effici aggreg induc emiss aie great sensit toward viscos medium abil triplet photosensit singlet oxygen generat photooxid describ photophys properti tri bdp various solvent solid state extens investig display effici aie green emiss acetonitrileeth mixtur red nm emiss solid state detail viscos depend studi suggest act fluoresc molecular rotor triplet photosensit singlet oxygen generat photooxid studi presenc diphenylisobenzofuran dihydroxyl naphthalen suggest high effici toward intersystem cross singlet oxygen generat detail electrochem investig suggest redox activ system henc system repres multifunct featur appli function materi various applic | D026082;D011789 | T170;T123;T196 |
36,217,603 | light activ trp channel found member trp channel superfamili drosophila light activ transient receptor potenti trp channel found member larg divers famili channel protein drosophila trp dtrp channel generat electr respons light investig great detail two decad first mammalian trp channel discov thus dtrp uniqu among member trp channel superfamili physiolog role enzymat cascad under activ establish articl outlin research lead elucid dtrp light activ channel focus major physiolog properti dtrp channel indirect activ via cascad enzymat reaction detail pioneer studi base genet dissect approach reveal light activ drosophila trp channel mediat g protein coupl receptor gpcr depend enzymat cascad phospholipas c plc crucial compon physiolog mechan drosophila trp channel activ later found mammalian trpc channel howev initi studi mammalian trpv channel indic activ direct capsaicin low ph hot temperatur c mechan activ appar odd activ mechan trpc channel general drosophila light activ trptrpl channel particular target gpcr activ plc cascad subsequ studi indic physiolog condit trpv also target gpcr activ plc cascad generat inflammatori pain drosophila light activ trp channel still use experiment paradigm physiolog function light activ channel known power genet techniqu appli analysi signal molecul involv activ channel avail | D050051;D029721 | T123;T116 |
36,217,587 | dentoskelet effect maxillari splint headgear earli correct class ii malocclus compar dentoskelet chang produc maxillari splint headgear cervic headgear applianc earli phase class ii treatment special initi overjet upper incisor posit | D008312;D057887 | T190 |
36,217,586 | nasomaxillari expans endoscop assist surgic expans eas airway centric approach aim studi analyz skelet dental airway chang endoscop assist surgic expans eas widen nasomaxillari complex treatment sleep apnea adult | D054893;D010155 | T061;T060 |
36,217,585 | studi success rate bond attach two differ composit choic composit type import factor affect success treatment aim studi compar failur rate two light cure composit evalu effect vivo two composit studi transbond xt bracepast american orthodont | D001840;D016910 | T061;T074 |
36,217,584 | compar studi excess glue around metal apc flash free adhes system aim vitro studi determin signific differ excess adhes flash metal apc flash free adhes system apc pre coat adhes system convent uncoat system | D001840;D016910 | T061;T074 |
36,217,583 | orthognath surgeri nasal obstruct orthognath surgeri aim treat facial dysmorphos relat anomali maxillomandibular complex surgic treatment often perform parallel orthodont treatment function aesthet purpos order provid effici manag obtain better stabil result simpl procedur must ad orthognath surgeri treat chronic nasal obstruct cno | D015508;D009300;D056948 | T061;T047;T023;T033 |
36,217,582 | assess soft tissu vs hard tissu chang isol function genioplasti studi aim determin vertic horizont soft tissu vs hard tissu chang isol function genioplasti revisit hard tissu remodel symphysi | D063172;D008334 | T061;T023;T030 |
36,217,581 | primari failur erupt tooth resorpt number adult patient seek orthodont treatment increas primari failur erupt pfe defin partial complet failur erupt least one posterior tooth without mechan obstacl better understand biolog mechan involv pfe would enabl refin diagnost prognost criteria rare diseas current relat pthr gene variant gene code transmembran receptor involv bone metabol howev evid associ pfe bone remodel abnorm extern root resorpt extern root resorpt loss cementum dentin tissu result activ clastic cell | D012391;D020254 | T047 |
36,217,577 | intrapopul varianc ecophysiolog respons water limit butterfli metapopul suggest adapt resili environment variabl organ part trophic network respond environment variabl small spatial scale studi multitud system prevail theori suggest larg role plastic key trait among interact speci allow match life cycl life histori trait across environment gradient instanc insect track host plant phenolog across variabl environ posledovich et al key aspect remain understudi extent intrapopul variabl plastic whether stress condit canal plastic optim level altern variat plastic inde could increas fit via altern strategi cover articl issu molecular ecolog kahilainen et al investig issu classic insect studi system metapopul glanvill fritillari butterfli melitea cinxia land archipelago finland author first establish key host plant respond water limit quantifi among famili variat larval growth develop across control water limit host plant final use rna sequenc gain mechanist insight among famili differ larval perform respons host plant variat find result suggest exist herit intrapopul variabl ecolog relev plastic final step repres critic import often overlook compon effort predict sensit biolog system chang environment condit sinc provid key metric adapt resili present system | D002080 | T204 |
36,217,574 | exercis train alter autoimmun cell invas brain autoimmun encephalomyel mechan exercis train et elicit benefici effect system immun system central nervous system cns autoimmun neuroinflamm fulli understood | D004681;D004660;D004679 | T050;T047 |
36,217,573 | potenti role obstruct sleep apnea pain sensit jaw function temporomandibular disord patient relationship obstruct sleep apnea osa divers type pain disord report howev interact osa pain relat temporomandibular disord tmd remain obscur | D059350;D009209;D020181;D013705 | T047;T184 |
36,217,572 | effect air pollut chemosensori dysfunct covid patient patient coronavirus diseas covid accompani loss smell tast report associ exposur air pollut studi investig relationship occurr chemosensori dysfunct covid patient air pollut concentr korea | D000393;D000397;D000086382;D010126 | T047;T131;T069;T103;T067;T080 |
36,217,571 | evalu hospit cluster covid associ patient prolong viral shed use whole genom sequenc patient hematolog malign may produc replic compet virus beyond day sar cov infect howev data regard transmiss sar cov patient prolong viral shed limit | D000086382 | T047;T067 |
36,217,570 | healthcar polici agenda sustain healthcar system korea build consensus use delphi method purpos studi suggest prioriti task necessari build sustain healthcar system korea base delphi consensus among healthcar profession | D003695;D006291 | T093;T058;T089 |
36,217,563 | electroretinographi adult high function autism spectrum disord electroretinogram erg allow investig retin signal pathway increas appli individu mental disord search potenti biomark neurodevelopment disord preced erg examin individu autism spectrum disord asd show inconsist result might due small number particip heterogen asd popul differ age rang stimul method aim studi investig function retin respons adult asd mean light adapt photop erg light adapt erg measur obtain retev system appli three differ stimul protocol final analysi erg paramet wave b wave photop negat respons phnr photop hill paramet well addit amplitud ratio compar adult high function asd non autist control group match regard sex age signific function retin differ amplitud peak time b wave phnr photop hill paramet erg amplitud ratio could detect individu asd compar non autist particip absenc electrophysiolog function retin alter asd suggest chang visual percept increas attent detail visual hypersensit asd due impair earli level retin signal process | D004596;D000067877 | T060;T048 |
36,217,553 | salvag transjugular intrahepat portosystem shunt patient cirrhosi refractori varic bleed systemat review meta analysi transjugular intrahepat portosystem shunt tip may use salvag treatment patient cirrhosi refractori varic bleed | D004932;D019168 | T061;T047;T020 |
36,217,543 | gsdmd contribut myocardi reperfus injuri regul pyroptosi gasdermin gsdmd play essenti role pathway pyroptosi howev whether gsdmd particip myocardi ischaemiareperfus injuri miri remain poor understood | D015428;D062645;D028044;D052899;D000072657 | T047;T046;T116;T061;T123 |
36,217,542 | safeti efficaci probiot supplement type inflammatori arthriti systemat review meta analysi random control trial evalu safeti efficaci probiot supplement inflammatori arthriti | D001172;D001851;D006073;D033461;D015212;D010024;D019936;D011565;D025241 | T007;T047 |
36,217,540 | qualiti chines govern environment health inform disclosur covid pandem satisfact survey univers student govern play vital role covid pandem disclos relat environment health inform public satisfact survey often use evalu public satisfact govern inform disclosur reflect problem current disclosur system univers student general better cognit skill effici receiv relat inform pandem therefor questionnair complet univers student select studi pandem qualiti govern environment health inform disclosur system rank margin higher averag moreov timeli content adequaci disclosur system rank level slight averag adopt hay process model studi found direct impact environment health knowledg environment health awar satisfact furthermor univers student environment health knowledg awar enhanc satisfact mediat effect self report environment behavior final studi attempt discov condit environment health knowledg awar would greater direct indirect influenc satisfact revers moder effect household incom level addit paper offer polici recommend enhanc qualiti govern environment health inform disclosur system | D000086382 | T047;T067 |
36,217,539 | associ physic activ dimens risk hypertens among middl older adult cross section studi china known insuffici physic activ associ risk hypertens relationship differ physic activ dimens within hypertens risk remain elucid | D015444;D006973 | T056;T061;T047 |
36,217,504 | meta analysi applic effect differ modal thermal ablat surgic treatment papillari thyroid microcarcinoma papillari thyroid microcarcinoma ptmc refer papillari thyroid carcinoma ptc maximum diamet mm thermal ablat includ radiofrequ ablat rfa microwav ablat mwa laser ablat la appli treatment benign thyroid nodul captur extens attent present applic thermal ablat ptmc extens report outcom volum reduct rate vrr complet remiss rate crr advers reaction rate arr vari consider therefor meta analysi perform evalu safeti efficaci differ treatment method ptmc | D002291;D017115;D000078703;D013964 | T191;T061 |
36,217,496 | multicent random open label phase ii clinic studi compar outcom nk paclitaxel advanc recurr breast cancer nk paclitaxel ptx incorpor core shell type polymer micellar nanoparticl formul compos block copolym polyethylen glycol polyamino acid efficaci safeti nk paclitaxel advanc recurr breast cancer never compar equival dose level | D001943;D010523 | T191;T047 |
36,217,495 | exosom exosom cargo promis world ventricular remodel follow myocardi infarct exosom pluripot group extracellular nanovesicl secret cell mediat intercellular communic effect inform within exosom primarili reflect exosom cargo includ protein lipid dnas non code rnas ncrnas intens studi molecul cardiac resid cell cardiomyocyt fibroblast endotheli cell foreign cell infiltr immun cell cardiac progenitor cell cardiospher deriv cell mesenchym stem cell involv progress ventricular remodel vr follow myocardi infarct mi via transfer exosom target cell summar patholog mechan vr follow mi includ cardiac myocyt hypertrophi cardiac fibrosi inflamm pyroptosi apoptosi autophagi angiogenesi metabol disord role exosom cargo process focus protein ncrnas continu research field reveal novel diagnost therapeut strategi vr | D055354;D035683;D009203 | T026;T123;T047;T114 |
36,217,450 | recent updat develop deuterium contain drug treatment cancer cancer one deadliest diseas world million cancer case million death report world suppos preval cancer case rise million chemotherapi base regimen narrow therapeut index sever advers drug reaction lack metabol stabil besid metabol anticanc produc sever non activ toxic metabolit reduc exposur target site parent drug therefor develop better toler effect new anticanc drug modif exist anticanc drug minim toxic increas efficaci becom urgent need deuterium incorpor reduc metabol certain drug breakdown pathway involv hydrogen carbon bond scission exampl cyp mediat oxid metabol drug involv breakdown hydrogen carbon bond affect deuter deuterium incorpor drug increas half life reduc dose provid better safeti efficaci deutetrabenazin first deuter form tetrabenazin approv treat chorea associ huntington diseas tardiv dyskinesia studi reveal deutetrabenazin fewer neuropsychiatr side effect favor safeti tetrabenazin current review highlight deuterium kinet isotop effect drug metabol deuter compound pharmacokinet properti safeti profil besid review explain deuter anticanc drug develop updat status | D006816;D009369;D000071057 | T191;T047 |
36,217,449 | combin zinc melatonin enhanc neuroprotect attenu neuropathi oxaliplatin induc neurotox present studi design investig possibl synergist effect melatonin zinc prevent treatment oxaliplatin induc neurotox rat | D008550;D020258;D010523 | T047;T037;T121;T109;T125 |
36,217,412 | kcnh enhanc hepat glucos metabol mitochondri ca regul oxid stress inhibit kcnh proven affect glucos metabol insulin secret human mice studi reveal kcnh knockout ko mice show impair glucos toler howev precis function kcnh liver remain unknown mitochondria suggest maintain intracellular ca homeostasi ros generat defect mitochondria caus glucos metabol disord includ type diabet td found kcnh attenu glucos metabol disord decreas pepck gpase abund induc glut ir express overexpress kcnh increas hepat glucos uptak glycogen synthesi kcnh attenu intracellular mitochondri calcium level primari hepatocyt reduc intracellular ros mitochondri superoxid product kcnh suppress oxid stress inhibit mitochondri pathway activ nadph oxidas express experi demonstr kcnh express improv hepat glucos metabol disord c jun n termin kinas p mapk signal pathway result confirm experi evalu extent forc kcnh express rescu metabol disord ko mice conclus kcnh enhanc hepat glucos metabol regul mitochondri ca level inhibit oxid stress liver glucos metabol key td understand kcnh function may provid new insight caus diabet | D003924;D051638;D005947;D008928;D018384 | T047;T116;T026;T049;T121;T109;T123;T043 |
36,217,389 | advanc cuffless continu blood pressur monitor technolog base ppg signal review progress research photoplethysmographi ppg base cuffless continu blood pressur monitor technolog prospect challeng need address futur | D001185;D063177 | T073;T060;T066;T081;T090 |
36,217,388 | hif promot bmp mediat osteoblast differenti vascular interact cbfa bone morphogenet protein bmp potent osteogen molecul initi differenti stem cell osteoblast lineag regul angiogenesi remain unclear bmp regul angiogen signal coupl osteogen pathway hypoxia induc factor hif critic vascular osteogen differenti cbfa known runt relat transcript factor runx play regulatori role osteogenesi studi investig combin effect hif runx bmp induc osteogen angiogen differenti immort mous embryon fibroblast imef effect hif runx osteogen angiogen differenti imef evalu relationship hif runx mediat angiogenesi bmp regul osteogen differenti imef evalu chip assay demonstr exogen express hif runx coupl potenti bmp induc osteogen angiogen differenti vitro anim model chromatin immunoprecipit assay chip show runx downstream target hif regul bmp mediat osteogenesi angiogen differenti find reveal hif immedi regul runx may origin essenti regulatori thread harmon osteogen angiogen differenti imef coupl hif runx essenti bone heal | D050659;D055427;D051795;D059630 | T025;T123;T116 |
36,217,332 | reveal lncrna biomark relat chronic obstruct pulmonari diseas base bioinformat chronic obstruct pulmonari diseas copd common chronic diseas respiratori tract high preval high disabl poor prognosi howev molecular mechan copd need reveal | D035683;D029424;D062085 | T047;T123;T114 |
36,217,331 | six minut walk test second chair stand test predictor mortal copd cohort studi physic inact strong associ wors prognosi chronic obstruct pulmonari diseas copd assess physic function import six minut walk test mwt establish test known predict mortal copd second chair stand test scst potenti altern test studi aim investig compar associ mwt scsts mortal | D029424 | T047 |
36,217,330 | defin high risk copd paramet respons map base machin learn model explor optim threshold fev predict valu fev pre high risk chronic obstruct pulmonari diseas copd use paramet respons map prm base machin learn classif model | D029424 | T047 |
36,217,309 | structur transit dynam intrins disord protein probe singl molecul spectroscopi intrins disord protein idp class protein follow unanim perspect structur function paradigm idp enunci dynam motion often difficult character particular experiment theoret approach chameleon natur idp result alter transit conform upon bind ligand experiment investig via ensembl averag approach probe random often difficult synchron thus sens substat differ conform ensembl idp research often target approach base singl molecul measur perspect discuss various singl molecul approach explor conform transit idp differ scenario outcom challeng futur prospect | D064267 | T123;T116 |
36,217,308 | renal fibrosi hallmark diabet kidney diseas potenti role target transform growth factor beta tgf relat molecul diabet kidney diseas dkd common caus end stage renal diseas esrd worldwid current effect treatment complet prevent dkd progress esrd renal fibrosi inflamm major patholog featur dkd pursu potenti therapeut target dkd | D003928;D035683;D007676;D003920 | T047;T123;T114 |
36,217,301 | web base train intervent increas physic activ level improv health adult intellectu disabl individu intellectu disabl id less physic activ higher bodi mass index bmi greater risk cardiovascular diseas cvds peopl without id purpos studi explor effect web base train programm consist min activ per week health peopl id | D008607 | T048 |
36,217,298 | predict diseas sever male individu ornithin transcarbamylas defici ornithin transcarbamylas defici otc x link metabol diseas common urea cycl disord due high phenotyp heterogen rang lethal neonat hyperammonem event moder symptom even asymptomat individu predict diseas cours earli diseas stage import individu adjust therapi medic treatment liver transplant translat studi develop sever adjust classif system base vitro residu enzymat otc activ | D020163;D022124 | T047 |
36,217,295 | hyperostosi frontali interna question patholog case report background hyperostosi frontali interna boney overgrowth inner side frontal bone skull caus overgrowth endocrani surfac often found women menopaus also associ hormon imbal overweight histori headach neurocognit degen condit femal gender advanc age extend estrogen stimul elev leptin level may also play role thicken usual confin frontal bone spread far anterior pariet tempor bone case report medic school dissect cours extens boney overgrowth frontal region cover insid frontal bone skull year old femal donor die cerebrovascular infarct identifi boney overgrowth main confin within frontal region boney overgrowth extend tempor bone overgrowth endocranium tempor bone sever overgrowth frontal bone morpholog overgrowth rigid uneven bumpi base upon physic characterist conclud present consist hyperostosi frontali interna conclus femal donor found exhibit phenomenon could clinic underdiagnos due intern natur asymptomat present insight potenti caus hfi identif clinic evalu offer path futur research better identifi manag case hfi | D006957 | T047 |
36,217,294 | build australia first mass spectromet recognis achiev j roger bird follow birth field mass spectrometri end world war sever decad first commerci mass spectromet becam avail interim mani physicist interest natur matter applic studi nuclear physic construct young physic postgradu student john roger bird first australia articl describ effort achiev featur technic blueprint photograph instrument earli data long overdu recognit bird work univers melbourn | D013058 | T059 |
36,217,291 | develop practic screen tool predict sarcopenia patient mainten hemodialysi background sarcopenia common complic mainten hemodialysi mhd increas patient hospit mortal simpl reliabl tool identifi sarcopenia exist aim develop screen tool predict mhd patient high risk sarcopenia materi method cross section studi includ mhd patient train valid set respect use diagnost criteria develop asian work group sarcopenia screen sarcopenia risk predict model establish univari multivari logist regress analys use area receiv oper characterist curv auroc calibr curv hosmer lemeshow test decis curv analysi dca evalu model discrimin abil calibr abil clinic util result incid sarcopenia train set valid set construct predict model appli age bodi mass index calf circumfer serum creatinin plot nomogram train set model auroc sensit specif chi squar valu hosmer lemeshow test p dca diagram show threshold probabl model predict net benefit sarcopenia mhd patient valid set model auroc sensit specif chi squar valu hosmer lemeshow test p conclus screen tool good discrimin abil calibr abil clinic util could help identifi mhd patient high risk sarcopenia | D055948 | T047 |
36,217,289 | reduc risk chronic graft versus host diseas cgvhd rabbit anti thymocyt globulin atg patient undergo match sibl donor transplant hematolog malign background addit anti thymocyt globulin atg gvhd prophylaxi patient undergo transplant peripher blood stem cell pbsct incid cgvhd decreas howev optim dose time atg remain undetermin materi method histor control trial data patient hematolog malign underw match sibl donor msd pbsct use analyz effect rabbit atg ratg prophylaxi gvhd forti patient receiv mgkg ratg use day patient receiv atg result patient success engraft except non atg group platelet engraft failur year cumul incid chronic gvhd cgvhd atg group versus non atg group ci versus ci p moder sever cgvhd ci versus ci p respect year cumul incid non relaps mortal relaps cir versus ci p ci versus ci p respect differ found surviv outcom multivari analysi atg independ protect factor moder sever cgvhd hr ci p independ poor risk factor cir hr ci p conclus atg strategi effect prophylaxi cgvhd wherea relaps rate increas patient ratg | D006086;D019337;D018380 | T191;T061;T047 |
36,217,269 | malign syphili young woman case report malign syphili ms rare dermatolog manifest secondari syphili case report describ young woman present day histori general condyloma lata seborrh dermat like lesion various stage laboratori test show toluidin red unheat serum test titr treponema pallidum particl agglutin posit serolog hiv antibodi repeat negat ms diagnos accord establish ms diagnost criteria lesion regress treatment unit penicillin g benzathin intramuscular inject week three consecut week ms frequent associ hiv infect patient make current case interest ms hiv negat patient rare report | D015658;D015497;D013587 | T047;T005 |
36,217,268 | advers event administr first second dose messeng rna base covid vaccin japanes subject age year use prospect observ design assess advers event ae covid vaccin japanes patient | D000086382;D000086663 | T047;T200;T067 |
36,217,266 | modul flexibl loop catalyt caviti reveal thermal activ mechan glycogen debranch enzym thermophil enzym exhibit high thermost high temperatur also activ effect thermal incub howev correl temperatur induc structur modul thermal activ still unclear studi select thermophil glycogen debranch enzym saccharolobus solfataricus stb ssgde promis starch debranch enzym thermal activ properti temperatur rang c explor thermal activ mechan molecular dynam simul perform ssgde c reveal temperatur depend structur modul catalyt function result reveal four loop loop loop loop loop ssgde reshap made catalyt caviti open intern residu includ catalyt triad asp glu asp could expos due structur modul exert catalyt function propos thermal activ effect ssgde close associ temperatur induc modul catalyt caviti pave way engin enzym achiev higher catalyt perform stabil | D006004 | T126;T116 |
36,217,263 | folat receptor posit circul tumor cell preoper diagnosi indetermin pulmonari nodul use fr ctc distinguish lung cancer benign lung diseas well studi howev effect method differenti precursor glandular lesion benignmalign pulmonari diseas rare | D008171;D008175;D009360 | T191;T047;T025 |
36,217,262 | identif novel compound heterozyg mutat myoa gene autosom recess non syndrom hear loss common inherit pattern respons congenit deaf belong autosom recess non syndrom hear loss arnshl mutat high heterogen myoa locus present larg proport case | D003638;D059472;D009218 | T047;T116;T028;T126;T184;T033 |
36,217,260 | clostridium subterminal infect patient diffus larg b cell lymphoma haemophagocyt syndrom case report literatur review although uncommon infect caus clostridium subterminal may life threaten particular immunocompromis patient report rare present patient diffus larg b cell lymphoma haemophagocyt syndrom associ c subterminal bacteraemia manag patient describ well review medic literatur infect clostridium speci includ c subterminal consid febril patient haematolog malign case highlight import use gene sequenc identif anaerob organ | D003015;D051359;D016403 | T191;T047;T037 |
36,217,259 | dramat cutan erupt nodular purpur lesion otherwis well older man describ dramat present rare condit present diffus ecchymosi like area entiti predilect primari cutan involv place dermatologist import primari assessor clinic knowledg high level clinic suspicion essenti time diagnosi click correspond question cme articl | D011693;D005076 | T047;T184 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.